As the country is battling the second and the worst wave of COVID-19 infections, the politics of vaccine and medicines has gained momentum. BJP parliamentarian Gautam Gambhir’s tweet on the availability of anti-COVID medicines at his office was rebuked by opposition, who charged the BJP of “hoarding” critical medicines in the time of crisis.

The BJP lawmaker on Wednesday tweeted that some of the anti-COVID medicines were being provided at his office free of cost.

Also Read | SC steps in, asks Centre to provide national plan on oxygen, medicines

His help-cum-information tweet did not go down well with the opposition, who were quick to attack him.

“This is the reason why Remdisivir, Fabiflu and other critical medicines are out of market. BJP leaders are hoarding these medicines. We have seen this in Gujarat also. Such leaders must be booked,” AAP leader Rajesh Sharma tweeted.

Congress’s Gaurav Pandhi also asked for an FIR against the BJP MP.

Congress spokesperson Pawan Kheda questioned if the “hoarding” was legal when there’s a shortage of these life-saving drugs in hospitals.

Also Read | Oxymeters, oxygen cans, steamers; Delhiites stock up amid COVID scare

Gautam Gambhir chose to respond with subtle digs.

The MP, who said that the city was his “home” and that he will help till his “last breath”, continued with his on-request task of providing help.

Each day, Delhi has been reporting record numbers of coronavirus cases. On Tuesday, the city logged over 28,000 cases in its biggest single-day spike since the pandemic started last year.

Also Read | ‘Beg, borrow or steal’: Delhi HC pulls up Centre over oxygen scarcity for COVID patients

Chief Minister Arvind Kejriwal announced the 6-day lockdown in the city starting at 10 pm on Monday.

The massive surge in the cases has brought the healthcare system in the national capital on the verge of collapse. Critical shortages of hospital beds, medicines, and life-saving oxygen have been reported in Delhi.

Notably, while Remdesivir is part of the prescribed treatment for COVID-19, Fabiflu is not. AIIMS Director Randeep Guleria, who is also a member of the national coronavirus task force, had cautioned against the overuse of drugs like Fabiflu.